Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Anterix Q2 Adj EPS $(0.27) Beats $(0.62) Estimate, Sales $1.05M Miss $1.08M Estimate

Author: Benzinga Newsdesk | November 13, 2023 06:15pm
Anterix (NASDAQ:ATEX) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.62) by 56.45 percent. This is a 51.79 percent increase over losses of $(0.56) per share from the same period last year. The company reported quarterly sales of $1.05 million which missed the analyst consensus estimate of $1.08 million by 2.59 percent. This is a 164.32 percent increase over sales of $398.00 thousand the same period last year.

Posted In: ATEX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist